ARQT Insider Transactions — Page 5
414 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 401–414; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Koppel Adam | TenPercentOwner | 2020-02-04 | Purchase | 294,117.0 | $17.0 |
| Bain Capital Life Sciences Fund, L.P. | TenPercentOwner | 2020-02-04 | Purchase | 294,117.0 | $17.0 |
| BCIP Life Sciences Associates, LP | TenPercentOwner | 2020-02-04 | Purchase | 294,117.0 | $17.0 |
| Schwartz Jeffrey Lawrence | TenPercentOwner | 2020-02-04 | Purchase | 294,117.0 | $17.0 |
| Bain Capital Life Sciences Partners, LP | TenPercentOwner | 2020-02-04 | Purchase | 294,117.0 | $17.0 |
| Bain Capital Life Sciences Investors, LLC | TenPercentOwner | 2020-02-04 | Purchase | 294,117.0 | $17.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2020-02-03 | Purchase | 176,500.0 | $17.0 |
| ORBIMED CAPITAL LLC | Director,TenPercentOwner | 2020-02-03 | Purchase | 176,500.0 | $17.0 |
| OrbiMed Capital GP VII LLC | Director,TenPercentOwner | 2020-02-03 | Purchase | 176,500.0 | $17.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2020-02-03 | Purchase | 382,388.0 | $17.0 |
| ORBIMED CAPITAL LLC | Director,TenPercentOwner | 2020-02-03 | Purchase | 382,388.0 | $17.0 |
| OrbiMed Capital GP VII LLC | Director,TenPercentOwner | 2020-02-03 | Purchase | 382,388.0 | $17.0 |
| SILVERSTEIN JONATHAN | Director,TenPercentOwner | 2020-02-03 | Purchase | 176,500.0 | $17.0 |
| SILVERSTEIN JONATHAN | Director,TenPercentOwner | 2020-02-03 | Purchase | 382,388.0 | $17.0 |